as on November 7, 2025 at 10:35 pm IST
Day's Low
Day's High
0.77%
Downside
5.42%
Upside
52 Week's Low
52 Week's High
66.00%
Downside
11.84%
Upside
Check Kymera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.3B
EPS (TTM)
-3.5152
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-18.88
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-321.5M
Revenue (TTM)
43.7M
Profit Margin
0.00%
Return On Equity TTM
-32.09%
Track how Kymera Therapeutics Inc P/E has moved over time to understand its valuation trends.
Kymera Therapeutics Inc in the last 5 years
Lowest (-43.30x)
March 31, 2021
Today (-18.88x)
November 7, 2025
Industry (8.36x)
November 7, 2025
Highest (-7.00x)
September 30, 2023
Today’s Price to Earnings Ratio: -18.88x
Compare market cap, revenue, PE, and other key metrics of Kymera Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $4.3B | 38.79% | -18.88 | 0.00% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Kymera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Kymera Therapeutics Inc investment value today
Current value as on today
₹1,19,808
Returns
₹19,808
(+19.81%)
Returns from Kymera Therapeutics Inc Stock
₹14,701 (+14.7%)
Dollar Returns*
₹5,107 (+5.11%)
Based on 23 analysts
69.57%
Buy
30.43%
Hold
0.00%
Sell
Based on 23 analysts, 69.57% of analysts recommend a 'BUY' rating for Kymera Therapeutics Inc. Average target price of $73.82
Get share price movements and forecasts by analysts on Kymera Therapeutics Inc.
What analysts predicted
22.53%UPSIDE
Target Price
$73.82
Current Price
$57.19
Analyzed by
23 Analysts
Target
$73.82
Kymera Therapeutics Inc target price $73.82, a slight upside of 22.53% compared to current price of $57.19. According to 23 analysts rating.
Search interest for Kymera Therapeutics Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, KYMR stock has moved up by 49.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 136.7%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 811.8%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 22.1M → 2.76M (in $), with an average decrease of 62.0% per quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, -65.58M → -82.17M (in $), with an average decrease of 12.0% per quarter
| Organisation | Kymera Therapeutics Inc |
| Headquarters | 500 North Beacon Street, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Dr. Nello Mainolfi M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Noah Goodman M.B.A. | Chief Business Officer |
Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
Dr. Jared A. Gollob M.D. | Chief Medical Officer |
Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
Dr. Juliet Williams B.A Ph.D. | Head of Research |
Dr. Bruce L. Booth DPHIL, Ph.D. | Co-Founder & Independent Chairman |
Dr. Jeremy G. Chadwick Ph.D. | Chief Operating Officer |
Ms. Karen Weisbach | Head of People & Culture |
Kymera Therapeutics Inc share price today is $57.19 as on . Kymera Therapeutics Inc share today touched a day high of $60.29 and a low of $56.75.
Kymera Therapeutics Inc share touched a 52 week high of $63.96 on and a 52 week low of $19.45 on . Kymera Therapeutics Inc stock price today i.e. is trending at $57.19,which is 10.58% down from its 52 week high and 194.11% up from its 52 week low.
Kymera Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Kymera Therapeutics Inc (KYMR) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Kymera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kymera Therapeutics Inc share’s latest price of $57.19 as on November 7, 2025 at 10:35 pm IST, you will get 0.1749 shares of Kymera Therapeutics Inc. Learn more about
fractional shares .
Kymera Therapeutics Inc stock has given 38.79% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?